Michael Gordon steps down as CEO, assumes role within Nordic Capital portfolio
Boston, Massachusetts, USA – November 30, 2023 – ArisGlobal, creator of the LifeSphere® technology platform and a market leader in global patient treatment solutions, announced today that its Board of Directors has appointed Aman Wasan to Chief Executive Officer. Aman was formerly Chief Commercial Officer and a member of ArisGlobal’s Executive Leadership team. He succeeds Michael Gordon, former CEO of ArisGlobal, who will assume a new role supporting several companies across the Nordic Capital portfolio.
“Aman is a proven leader and operator, has deep Life Sciences experience, and understands the technological innovation the industry is seeking,” shared Daniel Berglund, Co-Head of Healthcare and Partner at Nordic Capital Advisors. “In 2018, Aman joined ArisGlobal to help create its strategy toward next-gen technology, and while he held the role of Global Head of Pharmacovigilance, the company launched its market-leading LifeSphere SaaS offering. As the company continues to codify life sciences products into its LifeSphere platform, we are confident that Aman will help deliver the next phase of innovation and greater value to global customers.”
Aman has decades of experience across Life Sciences and software technology. Prior to ArisGlobal, he served as Global Head of Safety & Regulatory Service and Director of Board for Bioclinica. He has also worked in companies like Parexel and Novartis in different capacities.
“Having worked alongside Aman, I’ve experienced firsthand how his Life Sciences acumen adds tremendous value to the organization,” adds Michael Gordon. “We have made great progress as a company, and I am confident that ArisGlobal will continue its growth trajectory under Aman’s strong and able leadership.”
“LifeSphere – ArisGlobal’s scalable, interoperable, and industry-leading platform – is changing how pharmaceutical, biotech, and therapeutic companies are developing breakthroughs and bringing new patient treatments to market faster,” shared Aman, CEO of ArisGlobal. “As we move into this next phase of growth, we will be focused on continuing to drive innovation and delivering value, enabling a digital integrated patient vision, and unlocking the power of a unified R&D compliance platform.”
Aman continues, “I have immense appreciation for the leaders and teams who have built ArisGlobal into what it is today. I am honored to now guide the organization through its next evolution.”
About ArisGlobal
ArisGlobal is the creator of LifeSphere, a market leader in global patient treatment technology solutions that is transforming the way today’s most successful life sciences companies develop breakthroughs and bring new products to market. Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan, and China. For more updates, follow ArisGlobal on LinkedIn and www.arisglobal.com.
About Nordic Capital
Nordic Capital is a leading sector-specialized private equity investor with a resolute commitment to creating stronger, sustainable businesses through operational improvement and transformative growth. Nordic Capital focuses on selected regions and sectors where it has deep experience and a long history.
Focus sectors are Healthcare, Technology & Payments, Financial Services, and selectively, Industrial & Business Services. Key regions are Europe and globally for Healthcare and Technology & Payments investments. Since inception in 1989, Nordic Capital has invested EUR 23 billion in 140 investments. The most recent entities are Nordic Capital XI with EUR 9.0 billion in committed capital and Nordic Capital Evolution with EUR 1.2 billion in committed capital, principally provided by international institutional investors such as pension funds. Nordic Capital Advisors have local offices in Sweden, the UK, the US, Germany, Denmark, Finland, Norway, and South Korea.
For further information about Nordic Capital, please visit www.nordiccapital.com.
Download ArisGlobal’s 2024 Industry Report 
